Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

New research shows children and young people are bombarded with social media ads for junk food, which influence their food choices, but current rules do little to protect them.

Young teenage girl in a top tank sitting on the ground by the sofa and looking at her smart phone while eating a salty snack.

Children and teenagers are being exposed to hundreds of unhealthy food adverts every week on social media, according to a new study led by researchers at the Nuffield Department of Primary Care Health Sciences at the University of Oxford. 

The study, published in BMJ Global Health, reviewed research from around the world an found that food companies are using social media to target young people with advertising for ultra-processed foods high in fat, sugar, and salt. In some cases, children were found to be exposed to junk food ads nearly 200 times a week while using apps like Instagram, TikTok, and YouTube.  

The research showed that despite this type of digital marketing having a strong influence on children’s eating habits, making them more likely to choose unhealthy foods, there are not sufficient rules in place to protect children.  The research team call for urgent changes to govern the advertising of unhealthy food and help children make healthy choices.  

Food marketing shapes young peoples’ choices 

Social media is a key part of daily life for young people, and food companies are using increasingly sophisticated techniques to advertise their products. 

These include: 

  • Social media influencers promoting unhealthy snacks, making them appear more appealing. 

  • Interactive marketing, such as competitions and games that engage young users. 

  • Targeted advertising that reaches children based on their online behaviour and preferences. 

  • Quickly adaptable tactics, such as ‘COVID-washing’, where food brands used pandemic-related themes to market products. 

 

Read the full story on the The Nuffield Department of Primary Care Health Sciences website.

Similar stories

First clinical study in GSK-Oxford Experimental Medicine Collaboration starts as first patient dosed in ulcerative colitis experimental trial

The first patient in the PEGASUS clinical study, part of the GSK-University of Oxford Experimental Medicine Collaboration, received the first dose last week, on 8 October 2026.

Wearable chest patch could support hospital-level care at home, study finds

Researchers in Oxford have shown that wearable chest patches can be used to effectively monitor vital signs in many acutely unwell patients receiving hospital-level care in their own homes.

Brain immune cells protect neurons in Parkinson’s disease by “nibbling” harmful material

New research, published in Science Translational Medicine, reveals how a specialised population of the brain’s immune cells can remove harmful protein clumps from nerve cells (neurons), pointing to potential new treatments for Parkinson’s disease.

Phase I clinical study of ChAdOx1 BDBV vaccine launches in Uganda

The Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM Uganda Research Unit) has launched a Phase I clinical study evaluating the safety and immunogenicity of a candidate vaccine against Bundibugyo virus disease (BVD), a severe form of Ebola virus disease caused by Bundibugyo virus (BDBV), in partnership with the University of Oxford.

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.